# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA1068015 | B | Inhibition of N type calcium channel alpha-1b/alpha-2-delta-1/beta-1b expressed in HEK293 cells at holding potential of -100 mV by whole-cell patch clamp method | 50 | cell-based format | Scientific Literature | |||
2. | ALA1071416 | B | Inhibition of L-type calcium channel alpha-1c/alpha-2-delta-1/beta-1b expressed in HEK293 cells at 10 uM by FLIPR method | 22 | cell-based format | Scientific Literature | |||
3. | ALA3880754 | B | Antagonist activity at rat alpha1B N-type calcium channel expressed in HEK293 cells assessed as 0.067 Hz current frequency dependent channel blocking for 2 mins in presence of Ba2+ by whole-cell patch clamp assay | Rattus norvegicus | 33 | cell-based format | Patent Bioactivity Data | ||
4. | ALA3880755 | B | Antagonist activity at rat alpha1B N-type Ca2+ channel expressed in HEK293 cells assessed as 0.2 Hz current frequency dependent channel blocking for 2 mins in presence of Ba2+ by whole-cell patch clamp assay | Rattus norvegicus | 33 | cell-based format | Patent Bioactivity Data | ||
5. | ALA3880761 | B | Inhibition of human alpha1G T-type calcium channel expressed in HEK293 cells assessed as current dependent channel blocking at -110 mV holding potential with pre-pulse at -100 mV for 1 sec prior to test pulse at -40 mV for 50 ms by whole cell patch clamp assay | Homo sapiens | 11 | cell-based format | Patent Bioactivity Data |